Clinical trial
Effect of High-Flow Nasal Cannula Use on Exercise Tolerance and Physical Performance in Heart Failure Patients Enrolled in a Cardiac Rehabilitation Program: A Randomized Crossover Trial
NCT07613762 is registered in ClinicalTrials.gov with Universidad de Santiago de Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of High-Flow Nasal Cannula Use on Exercise Tolerance and Physical Performance in Heart Failure Patients Enrolled in a Cardiac Rehabilitation Program: A Randomized Crossover Trial
- Lead sponsor
- Universidad de Santiago de Chile
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- March 31, 2027
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac rehabilitation, exercise tolerance (measured in minutes), heart failure